Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	40,889	43,584	51,100	44,775	56,890	47,514
Market Cap Growth	-14.71%	-14.71%	14.13%	-21.30%	19.73%	48.86%
Enterprise Value	73,114	77,944	85,454	78,699	97,278	93,248
PE Ratio	46.43	45.80	21.34	23.72	16.48	115.88
PS Ratio	1.45	1.55	1.68	1.53	1.94	1.56
PB Ratio	0.91	0.91	1.07	0.96	1.20	1.09
P/FCF Ratio	12.01	12.01	8.08	5.45	6.55	9.23
P/OCF Ratio	9.21	9.21	6.92	4.86	6.13	7.65
EV/Sales Ratio	2.60	2.77	2.81	2.69	3.31	3.06
EV/EBITDA Ratio	11.80	11.79	9.36	9.12	9.02	14.63
EV/EBIT Ratio	43.31	43.30	20.77	20.45	17.23	96.56
EV/FCF Ratio	21.48	21.47	13.51	9.58	11.20	18.12
Debt / Equity Ratio	0.78	0.78	0.80	0.88	1.04	1.18
Debt / EBITDA Ratio	5.67	5.67	4.22	4.76	4.60	8.12
Debt / FCF Ratio	10.33	10.33	6.09	5.00	5.71	10.06
Quick Ratio	0.49	0.49	0.48	0.73	1.01	0.65
Current Ratio	1.11	1.11	0.97	1.21	1.53	1.14
Asset Turnover	0.29	0.29	0.29	0.28	0.26	0.25
Interest Coverage	1.24	1.24	3.21	2.82	2.47	0.63
Return on Equity (ROE)	2.10%	2.10%	5.00%	4.30%	7.90%	0.90%
Return on Assets (ROA)	1.00%	1.00%	2.30%	1.80%	3.00%	0.30%
Return on Capital (ROIC)	4.52%	4.52%	3.62%	3.28%	4.95%	0.97%
Earnings Yield	2.33%	2.18%	4.69%	4.22%	6.07%	0.86%
FCF Yield	8.33%	8.33%	12.38%	18.35%	15.27%	10.83%
Dividend Yield	4.69%	0.00%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	215.79%	0.00%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-1.20%	-1.20%	0.83%	-0.36%	0.46%	-99.75%
Total Shareholder Return	3.49%	-1.20%	0.83%	-0.36%	0.46%	-99.75%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).